PL415767A1 - Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie - Google Patents

Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie

Info

Publication number
PL415767A1
PL415767A1 PL415767A PL41576716A PL415767A1 PL 415767 A1 PL415767 A1 PL 415767A1 PL 415767 A PL415767 A PL 415767A PL 41576716 A PL41576716 A PL 41576716A PL 415767 A1 PL415767 A1 PL 415767A1
Authority
PL
Poland
Prior art keywords
tissue adhesive
composition
obtaining
applications
inefficient
Prior art date
Application number
PL415767A
Other languages
English (en)
Other versions
PL229593B1 (pl
Inventor
Renata Wawrzaszek
Original Assignee
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority to PL415767A priority Critical patent/PL229593B1/pl
Priority to PCT/PL2017/050002 priority patent/WO2017123109A1/en
Publication of PL415767A1 publication Critical patent/PL415767A1/pl
Publication of PL229593B1 publication Critical patent/PL229593B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L24/0089—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie w codziennej praktyce chirurgicznej, zwłaszcza do zamykania i uszczelniania niewydolnych naczyń układu żylnego lub wrodzonych anomalii naczyniowych. Kompozycja kleju tkankowego do zamykania i uszczelniania niewydolnych naczyń układu żylnego lub wrodzonych anomalii naczyniowych charakteryzuje się tym, że zawiera: od 85 do 86% wag. poli(metylo-winylo-siloksanu), od 5,4 - 6,5% wag. dwutlenku krzemu oraz od 8,5 do 8,6% wag związku sieciującego. Przy czym stosunek poli(metylo-winylo-siloksanu) do dwutlenku krzemu wynosi 13 : 1 do 16 : 1.
PL415767A 2016-01-12 2016-01-12 Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie PL229593B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL415767A PL229593B1 (pl) 2016-01-12 2016-01-12 Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie
PCT/PL2017/050002 WO2017123109A1 (en) 2016-01-12 2017-01-10 Tissue adhesive composition, a method of producing it, and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL415767A PL229593B1 (pl) 2016-01-12 2016-01-12 Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie

Publications (2)

Publication Number Publication Date
PL415767A1 true PL415767A1 (pl) 2017-07-17
PL229593B1 PL229593B1 (pl) 2018-08-31

Family

ID=58108709

Family Applications (1)

Application Number Title Priority Date Filing Date
PL415767A PL229593B1 (pl) 2016-01-12 2016-01-12 Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie

Country Status (2)

Country Link
PL (1) PL229593B1 (pl)
WO (1) WO2017123109A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3667472A (en) 1961-10-19 1972-06-06 Borden Inc Adhesive for living tissue
US6174919B1 (en) 1998-02-18 2001-01-16 Closure Medical Corporation Cyanoacrylate compositions with vinyl terminated ester groups
US7459142B2 (en) * 2002-06-06 2008-12-02 Micro Therapeutics, Inc. High viscosity embolizing compositions comprising prepolymers
WO2006026412A2 (en) * 2004-08-31 2006-03-09 Vnus Medical Technologies, Inc. Apparatus and material composition for permanent occlusion of a hollow anatomical structure
KR100650453B1 (ko) 2005-06-04 2006-11-27 주식회사 예스바이오 골대체용 복합재료

Also Published As

Publication number Publication date
PL229593B1 (pl) 2018-08-31
WO2017123109A1 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
BR112018070187A2 (pt) receptores quiméricos para flt3 e seus métodos de uso
MX361514B (es) Composiciones de limpieza para cuidado personal libres de sulfato.
EP3411504A4 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE-1 DIABETES
EA201992176A1 (ru) Пробиотические молекулы для снижения вирулентности патогена
BR112019023059A8 (pt) Composições de limpeza melhoradas
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
IL273484A (en) A33 antibody preparations and methods for their use in radioimmunotherapy
EA201992175A1 (ru) Композиции и способы, включающие пробиотические молекулы
TN2018000417A1 (en) Anti-coagulation factor xi antibodies.
CY1123892T1 (el) Κρυσταλλικες μορφες του 6-((6,7-διμεθοξυκιναζολιν-4-υλο)οξυ)-ν,2-διμεθυλοβενζοφουρανο-3-καρβοξαμιδιου
EP3647312A4 (en) AZD9291 DEUTERATE CRYSTALLINE FORM, RELATED PREPARATION PROCESS AND RELATED USE
MX2017013534A (es) Composiciones concentradas para la limipieza personal y usos.
PH12019501945A1 (en) Composition and method for preventing or delaying onset of myopia comprising atropine
EP4328241A3 (en) Multispecific molecules comprising a non-immunoglobulin heterodimerization domain and uses thereof
WO2018085533A3 (en) Anti-cd40 antibodies in combination and methods of use
EA201692064A1 (ru) Композиция для личной гигиены
EA201400541A1 (ru) Косметическая композиция
BR112014014572A2 (pt) composição bioativa
PL415767A1 (pl) Kompozycja kleju tkankowego, sposób jej otrzymywania i zastosowanie
CA3056612A1 (en) Analogs of deutetrabenazine, their preparation and use
MX2017009406A (es) Compuestos de tipo isoergolina y usos de estos.
EP3606532A4 (en) COMPOSITIONS AND METHODS OF TREATING AN INFECTION AND NEW COSMECEUTIC PREPARATIONS
MX2018015431A (es) Composicion cosmetica anti-signos, uso de la composicion, metodo de tratamiento anti-signos y dispositivo aplicador.
SG11201900768TA (en) Composition for inhibiting sebum secretion comprising peach sprout extract
PL3643288T3 (pl) Ciecze posiadające właściwości samoemulgujące typu olej w wodzie, kompozycje, zastosowania i sposoby z nimi związane